Pregabalin Versus Placebo as an Add on for Complex Regional Pain Syndrome (CPRS) of the Upper Limb Managed by Stellate Ganglion Block (The PREGA Study) (PREGA)
Pregabalin vs. Placebo as an Add on for Complex Regional Pain Syndrome of the Upper Limb Managed by Stellate Ganglion Block
Sponsor: Hamilton Health Sciences Corporation
Terminated
Unable to recruit patients
Other terminated trials from Hamilton Health Sciences Corporation
- Antibiotic Prophylaxis · Phase NA · Mar 2025
- Opioid Use · Phase PHASE3 · Sep 2022
- Obsessive-Compulsive Disorder · Phase PHASE4 · Apr 2021
- Stroke · Phase NA · Sep 2020
- Social Phobia · Phase PHASE4 · Dec 2018
More terminations from Hamilton Health Sciences Corporation
Other Complex Regional Pain Syndromes trials with similar outcome
A NA clinical study on Complex Regional Pain Syndromes, this trial is terminated or withdrawn. The trial is conducted by Hamilton Health Sciences Corporation and has accumulated 5 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
Jun 2018 — Jan 2021 [monthly]
Terminated NA
-
Jan 2017 — Jun 2018 [monthly]
Terminated NA
First recorded
Nov 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Hamilton Health Sciences Corporation
- McMaster University
- Pfizer
For direct contact, visit the study record on ClinicalTrials.gov .